Cognition Therapeutics, Inc. (CGTX) Analyst Estimates Annual - Discounting Cash Flows
CGTX
Cognition Therapeutics, Inc.
CGTX (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
Number of Analysts 1 1 1 2 2 0
Estimated Revenue
Low 63.7 4.3 41.93 19 16 0
Average 63.7 4.3 41.93 19 16 0
High 63.7 4.3 41.93 19 16 0
Estimated EBITDA
Low 0 0 0 0 0 0
Average 0 0 0 0 0 0
High 0 0 0 0 0 0
Estimated EBIT
Low 0 0 0 0 0 0
Average 0 0 0 0 0 0
High 0 0 0 0 0 0
Estimated Net Income
Low -21.85 -25.43 -17.08 -18.01 -15.94 -35.5
Average -21.85 -25.43 -17.08 -13.11 -15.49 -32.99
High -21.85 -25.43 -17.08 -8.22 -15.05 -25.3
Estimated SGA Expenses
Low 0 0 0 0 0 0
Average 0 0 0 0 0 0
High 0 0 0 0 0 0
Estimated EPS
Low -0.55 -0.64 -0.43 -0.453 -0.401 -0.894
Average -0.55 -0.64 -0.43 -0.335 -0.39 -0.822
High -0.55 -0.64 -0.43 -0.207 -0.379 -0.637
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program